MLAB Stock Down -23% after 7-Day Loss Streak
Mesa Laboratories (MLAB) stock hit day 7 of a continuous streak of days with losses, with cumulative losses over this period amounting to a -23% return. The company has lost about $103 Mil in value over the last 7 days, with its current market capitalization at about $451 Mil. The stock remains 41.0% below its value at the end of 2024. This compares with year-to-date returns of 6.2% for the S&P 500.
Comparing MLAB Stock Returns With The S&P 500
The following table summarizes the return for MLAB stock vs. the S&P 500 index over different periods, including the current streak:
| Return Period | MLAB | S&P 500 |
|---|---|---|
| 1D | -6.4% | -0.4% |
| 7D (Current Streak) | -22.9% | 0.3% |
| 1M (21D) | -25.8% | 3.7% |
| 3M (63D) | -29.3% | 18.5% |
| YTD 2025 | -41.0% | 6.2% |
| 2024 | 26.6% | 23.3% |
| 2023 | -36.6% | 24.2% |
| 2022 | -49.2% | -19.4% |
Gains and Losses Streaks: S&P 500 Constituents
There are currently 9 S&P constituents with 3 days or more of consecutive gains and 153 constituents with 3 days or more of consecutive losses.
| Consecutive Days | # of Gainers | # of Losers |
|---|---|---|
| 3D | 2 | 124 |
| 4D | 1 | 13 |
| 5D | 5 | 12 |
| 6D | 1 | 2 |
| 7D or more | 0 | 2 |
| Total >=3 D | 9 | 153 |
Key Financials for Mesa Laboratories (MLAB)
Last 2 Fiscal Years:
| Metric | FY2024 | FY2025 |
|---|---|---|
| Revenues | $216.2 Mil | $241.0 Mil |
| Operating Income | $2.5 Mil | $16.3 Mil |
| Net Income | $-254.2 Mil | $-2.0 Mil |
Last 2 Fiscal Quarters:
| Metric | 2025 FQ3 | 2025 FQ4 |
|---|---|---|
| Revenues | $62.8 Mil | $62.1 Mil |
| Operating Income | $5.8 Mil | $1.5 Mil |
| Net Income | $-1.7 Mil | $-7.1 Mil |
The losing streak MLAB stock is currently on doesn’t inspire much confidence among investors. In contrast, Trefis High Quality (HQ) Portfolio, with a collection of 30 stocks, has a track record of comfortably outperforming the S&P 500 over the last 4-year period. Why is that? As a group, HQ Portfolio stocks provided better returns with less risk versus the benchmark index; less of a roller-coaster ride, as evident in HQ Portfolio performance metrics.